| 摘要 |
<p>A process for crystallizing recombinant human interleukin-4 (rhu IL-4) from a solution containing a sulfate or citrate salt is described. The crystalline form is suitable for x-ray diffraction and has wide applications in several pharmaceutical processes including purification, formulation and manufacturing.</p> |
